search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
GLP-1 WEIGHT- LOSS DRUGS HIT FOODSERVICE INDUSTRY


Te soaring popularity of weight- loss drugs has prompted changes to restaurant menus from operators keen to tap into the trend, as Helen Roxburgh reports


M


edications such as Ozempic, Wegovy and Mounjaro – known as GLP-1 drugs and normally injected – mimic


the hormone that signals when a person is full, helping them to eat less. Te numbers taking these drugs has


grown so much that it is being compared to catering for vegans, or people with allergies – and with such a large increase, experts argue the trend could have far- reaching impacts.


A LASTING BEHAVIORAL SHIFT


Morgan Stanley has predicted that the global market for obesity drugs could reach $150bn at its peak in 2035. In 2024, this market had about $15bn in sales. “Obesity drug patients continue to


report eating healthier foods, spending less on groceries or cutting back on restaurant expenses,” says analyst Tibault Boutherin. “Given the impact on appetite, this could


62


drive a broad and lasting behavioral shift among a sizable demographic group – a group that accounts for a disproportionate share of food and beverage consumption.” Among brands adapting to the new


trend is American chain Cuba Libre, which has introduced a “GLP-Wonderful” menu to “meet the needs of our guests using these medications”. Te group says the special menu, priced


around 25% lower than the regular menu, features “five flavorful entrees that fit within GLP-1 nutritional guidelines with a focus on smaller portions, high protein and fiber”. Similarly, UK chef Heston Blumenthal


has added a slimmed-down tasting menu at his Michelin-starred fine dining venue the Fat Duck, which launched a Mindful Experience menu in September. Te new menu is pared down to offer reduced-size plates it says will


address diners’ “evolving appetites.” “For all sorts of reasons – health, appetite suppressant drugs, changing social expectations, current economic realities, or even just the preference to eat less – people are looking to eat differently, more mindfully,” said Blumenthal when he launched it.


PREPARE FOR THE CHANGING TREND


Bettina von Massenbach FCSI, founder of Germany-based consultancy Oyster Hospitality, says restaurant operators should be “prepared” for the changing trend and must “consider guests’ changing eating habits in the future.” Research from the Institute of Grocery


Distribution shows that uptake among UK adults for weight-loss medications has grown from 3.1% in June 2025 to 4.2% in October – more than the number following a vegan diet.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68